Donate Now
Donate Now

Category

Uncategorized
Lung infections caused by Mycobacterium abscessus are emerging worldwide and are very difficult to treat, because of the bacterium’s resistance to most classes of antibiotics. The research group led by Jakko van Ingen, clinical microbiologist at Radboudumc (Nijmegen, the Netherlands), has discovered that inhalation of an old antibiotic, tigecycline, may finally improve treatment outcomes of...
Read More
Most of us will be staying away from other people and in our homes for the next several weeks (at least), but in addition to taking a stroll outside (staying appropriately distanced from others), there are some great virtual activities you can partake in online. Many public libraries have gone digital; you can become a...
Read More
The FDA workshop on “The Development of Antibiotics for the Treatment of NTM Disease” on April 8, 2019 was very successful, with more than 100 people attending in person. The agenda focused on issues surrounding clinical trials and the development of a validated Patient-Reported Outcome (PRO) tool. Panelists included experts in NTM and in PRO,...
Read More
The Food and Drug Administration is convening a public workshop titled “Development of Inhaled Antibacterial Drugs for Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis” on Wednesday, June 27th from 8:30pm to 4:30pm ET. The purpose of this workshop is to discuss the clinical trial design challenges and future considerations for inhaled antibacterial products to treat cystic...
Read More

WHAT IS NTM?

“NTM” is short for Nontuberculous Mycobacteria. NTM disease is a serious chronic lung illness.

Learn More

 

Responsive WordPress Theme Freetheme wordpress magazine responsive freetheme wordpress news responsive freeWORDPRESS PLUGIN PREMIUM FREEDownload theme freeDownload html5 theme free - HTML templates Free Top 100+ Premium WordPress Themes for 2017 Null24Món ngon chữa bệnhCây thuốc chữa bệnhNấm đông trùng hạ thảo